Monday, October 7, 2013

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine — NEJM

Retweeted NEJM (@NEJM): DNA/rAd5 HIV preventive vaccine reduced neither HIV-1 acquisition nor post-acquisition viral load. http://t.co/6vw3vuT2Zk #AIDSVAX2013

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/6vw3vuT2Zk
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)